Free Trial

MetLife (MET) Competitors

MetLife logo
$76.25 +2.43 (+3.29%)
Closing price 03:59 PM Eastern
Extended Trading
$76.40 +0.16 (+0.20%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MET vs. AFL, AIZ, AMP, CNO, EQH, ORI, PFG, PRU, RDN, and UNM

Should you be buying MetLife stock or one of its competitors? The main competitors of MetLife include Aflac (AFL), Assurant (AIZ), Ameriprise Financial (AMP), CNO Financial Group (CNO), Equitable (EQH), Old Republic International (ORI), Principal Financial Group (PFG), Prudential Financial (PRU), Radian Group (RDN), and Unum Group (UNM). These companies are all part of the "finance" sector.

MetLife vs. Its Competitors

MetLife (NYSE:MET) and Aflac (NYSE:AFL) are both large-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

In the previous week, MetLife had 21 more articles in the media than Aflac. MarketBeat recorded 57 mentions for MetLife and 36 mentions for Aflac. Aflac's average media sentiment score of 0.93 beat MetLife's score of 0.50 indicating that Aflac is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MetLife
21 Very Positive mention(s)
6 Positive mention(s)
24 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Positive
Aflac
17 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

95.0% of MetLife shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 0.4% of MetLife shares are owned by company insiders. Comparatively, 0.9% of Aflac shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Aflac has a net margin of 15.32% compared to MetLife's net margin of 5.83%. MetLife's return on equity of 19.72% beat Aflac's return on equity.

Company Net Margins Return on Equity Return on Assets
MetLife5.83% 19.72% 0.82%
Aflac 15.32%15.08%3.21%

MetLife presently has a consensus price target of $95.40, indicating a potential upside of 25.11%. Aflac has a consensus price target of $107.92, indicating a potential upside of 4.30%. Given MetLife's stronger consensus rating and higher possible upside, analysts plainly believe MetLife is more favorable than Aflac.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MetLife
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.91
Aflac
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

MetLife pays an annual dividend of $2.27 per share and has a dividend yield of 3.0%. Aflac pays an annual dividend of $2.32 per share and has a dividend yield of 2.2%. MetLife pays out 38.5% of its earnings in the form of a dividend. Aflac pays out 52.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MetLife has increased its dividend for 12 consecutive years and Aflac has increased its dividend for 44 consecutive years. MetLife is clearly the better dividend stock, given its higher yield and lower payout ratio.

MetLife has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Aflac has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500.

Aflac has lower revenue, but higher earnings than MetLife. MetLife is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MetLife$70.99B0.72$4.43B$5.9012.92
Aflac$18.93B2.96$5.44B$4.4123.46

Summary

MetLife beats Aflac on 11 of the 19 factors compared between the two stocks.

Get MetLife News Delivered to You Automatically

Sign up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MET vs. The Competition

MetricMetLifeINS IndustryFinance SectorNYSE Exchange
Market Cap$51.19B$20.93B$12.16B$20.68B
Dividend Yield2.99%2.96%5.64%3.69%
P/E Ratio12.9211.8219.8628.53
Price / Sales0.722.0326.1766.35
Price / Cash10.5816.8421.4923.60
Price / Book1.912.012.114.31
Net Income$4.43B$1.62B$1.00B$996.14M
7 Day Performance3.04%3.33%1.26%1.93%
1 Month Performance-4.34%0.45%0.17%-0.54%
1 Year Performance9.44%21.43%543.56%14.79%

MetLife Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MET
MetLife
4.9911 of 5 stars
$76.25
+3.3%
$95.40
+25.1%
+7.4%$51.19B$70.99B12.9245,000Trending News
Earnings Report
Ex-Dividend
Analyst Forecast
AFL
Aflac
4.5775 of 5 stars
$98.60
+0.5%
$108.15
+9.7%
+2.9%$53.31B$18.93B15.4112,694Earnings Report
Dividend Announcement
Analyst Forecast
AIZ
Assurant
4.764 of 5 stars
$188.93
+1.3%
$228.83
+21.1%
+18.4%$9.61B$11.88B14.7314,200Earnings Report
Analyst Revision
AMP
Ameriprise Financial
4.5649 of 5 stars
$506.51
+1.3%
$534.71
+5.6%
+26.8%$48.23B$17.47B15.7613,600Positive News
CNO
CNO Financial Group
4.5807 of 5 stars
$35.85
+1.0%
$43.40
+21.1%
+15.3%$3.55B$4.38B13.233,500Dividend Announcement
EQH
Equitable
4.5479 of 5 stars
$51.03
+1.9%
$65.30
+28.0%
+35.5%$15.39B$14.78B13.878,000Positive News
Ex-Dividend
Analyst Forecast
ORI
Old Republic International
4.4667 of 5 stars
$36.33
+1.2%
$41.50
+14.2%
+10.7%$8.98B$8.23B12.449,400Positive News
PFG
Principal Financial Group
4.3538 of 5 stars
$75.88
+0.5%
$86.70
+14.3%
+3.4%$16.90B$15.13B11.3619,300Positive News
PRU
Prudential Financial
4.73 of 5 stars
$101.78
+1.1%
$121.75
+19.6%
-5.6%$35.83B$68.05B22.5738,196Dividend Announcement
RDN
Radian Group
2.4697 of 5 stars
$32.86
-0.2%
$37.00
+12.6%
-0.5%$4.41B$1.29B8.281,400Positive News
Analyst Revision
UNM
Unum Group
4.966 of 5 stars
$70.00
+0.4%
$91.62
+30.9%
+29.7%$11.92B$12.89B8.3711,063

Related Companies and Tools


This page (NYSE:MET) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners